Key result
COVID-19 lockdown does not impact overall arrhythmias or ICD therapies despite fewer non-sustained ventricular tachycardias.
Why the study?
The potential individual health effects of long-term isolation during COVID-19 lockdown, including arrhythmic consequences in patients with ICDs, were largely unknown.
Does the COVID-19 lockdown impact the incidence of arrhythmias and ICD therapies in patients with ICDs?
Observational (n=413)
No
Does the COVID-19 lockdown impact the incidence of arrhythmias and ICD therapies in patients with ICDs?
The COVID-19 lockdown did not increase the incidence of major arrhythmias or ICD therapies in patients with ICDs, though it was associated with a decrease in non-sustained ventricular tachycardias.
Answers are grounded in this paper and cite their sources.
No rise in arrhythmias or ICD therapies during lockdown warrants no practice change; leaves open mechanisms of reduced NSVT.
BACKGROUND: In Italy, a nationwide full lockdown was declared between March and May 2020 to hinder the novel coronavirus disease 2019 (COVID-19) pandemic. The potential individual health effects of long-term isolation are largely unknown. The current study investigated the arrhythmic consequences of the COVID-19 lockdown in patients with defibrillators (ICDs) living in the province of Ferrara, Italy. METHODS: Both the arrhythmias and the delivered ICD therapies as notified by the devices were prospectively collected during the lockdown period (P1) and compared to those occurred during the 10 weeks before the lockdown began (P2) and during the same period in 2019 (P3). Changes in outcome over the three study periods were evaluated for significance using McNemar's test. RESULTS: A total of 413 patients were included in the analysis. No differences were found concerning either arrhythmias or shocks or anti-tachycardia pacing. Only the number of patients experiencing non-sustained ventricular tachycardias (NSVTs) during P1 significantly decreased as compared to P2 (p = 0.026) and P3 (p = 0.009). The subgroup analysis showed a significant decrease in NSVTs during P1 for men (vs. P2, p = 0.014; vs. P3, p = 0.040) and younger patients (vs. P2, p = 0.002; vs. P3, p = 0.040) and for ischemic etiology (vs. P2, p = 0.003). No arrhythmic deaths occurred during P1. CONCLUSIONS: The complete nationwide lockdown, as declared by the Italian government during the first COVID-19 pandemic peak, did not impact on the incidence of arrhythmias in an urban cohort of patients with ICDs.
No takes yet. Share an insight, caveat, or question.
Sassone et al. (2021) conducted an observational in Patients with implantable cardioverter-defibrillators (ICDs) (n=413). COVID-19 lockdown vs. 10 weeks before lockdown and the same period in 2019 was evaluated on Arrhythmias and delivered ICD therapies (shocks or anti-tachycardia pacing). The COVID-19 lockdown did not impact overall arrhythmias or ICD therapies in patients with ICDs, though non-sustained ventricular tachycardias decreased vs pre-lockdown.
Synapse has enriched 10 related papers. Consider them for comparative context: